Stocks and InvestingStocks and Investing
Fri, November 3, 2017
Thu, November 2, 2017
Wed, November 1, 2017
Tue, October 31, 2017
Mon, October 30, 2017

Geoffrey Porges Maintained (ABBV) at Buy with Decreased Target to $107 on, Oct 30th, 2017


Published on 2024-10-26 00:14:52 - WOPRAI, Geoffrey Porges
  Print publication without navigation


Geoffrey Porges of Leerink Swann, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $108 to $107 on, Oct 30th, 2017.

Geoffrey has made no other calls on ABBV in the last 4 months.



There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 3 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
  • Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
  • Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Increased Target to $66 on, Monday, July 17th, 2017


These are the ratings of the 3 analyists that currently disagree with Geoffrey


  • Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017
  • Jeffrey Holford of "Jefferies" Maintained at Strong Buy with Increased Target to $107 on, Friday, September 15th, 2017
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $95 on, Thursday, August 17th, 2017